Related references
Note: Only part of the references are listed.Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Khurram J. Khan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases
Benoit Chassaing et al.
GASTROENTEROLOGY (2011)
Nod2 is essential for temporal development of intestinal microbial communities
Ateequr Rehman et al.
GUT (2011)
Suppression of Hath1 Gene Expression Directly Regulated by Hes1 Via Notch Signaling Is Associated with Goblet Cell Depletion in Ulcerative Colitis
Xiu Zheng et al.
INFLAMMATORY BOWEL DISEASES (2011)
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1
Bjoern O. Schroeder et al.
NATURE (2011)
Association of Higher DEFB4 Genomic Copy Number With Crohn's Disease
Robert W. Bentley et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria
Chin Wen Png et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Phosphatidylcholine (Lecithin) and the Mucus Layer: Evidence of Therapeutic Efficacy in Ulcerative Colitis?
Wolfgang Stremmel et al.
DIGESTIVE DISEASES (2010)
Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis - a review of three clinical trials
Wolfgang Stremmel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease
Marian C. Aldhous et al.
HUMAN MOLECULAR GENETICS (2010)
Toll-like Receptors in Inflammatory Bowel Diseases: A Decade Later
Elke Cario
INFLAMMATORY BOWEL DISEASES (2010)
Paneth's disease
Jan Wehkamp et al.
JOURNAL OF CROHNS & COLITIS (2010)
Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum
Amlan Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
Laurent Peyrin-Biroulet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Intestinal epithelial cells in inflammatory bowel diseases
Giulia Roda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis
Michael Gersemann et al.
DIFFERENTIATION (2009)
Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease
Maureen J. Koslowski et al.
PLOS ONE (2009)
Impaired luminal processing of human defensin-5 in Crohn's disease - Persistence in a complex with chymotrypsinogen and trypsin
David Elphick et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Microbial influences in inflammatory bowel diseases
R. Balfour Sartor
GASTROENTEROLOGY (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease
L. A. Simms et al.
GUT (2008)
Secreted enteric antimicrobial activity localises to the mucus surface layer
U. Meyer-Hoffert et al.
GUT (2008)
European evidence-based Consensus on the management of ulcerative colitis: Current management
S. P. L. Travis et al.
JOURNAL OF CROHNS & COLITIS (2008)
Crohn's disease - Defect in innate defence
Michael Gersemann et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Innate immunity in inflammatory bowel disease
Jesus K. Yamamoto-Furusho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Phosphatidylcholine for steroid-refractory chronic ulcerative colitis - A randomized trial
Wolfgang Stremmel et al.
ANNALS OF INTERNAL MEDICINE (2007)
The Paneth cell α-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4
Jan Wehkamp et al.
JOURNAL OF IMMUNOLOGY (2007)
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Daniel N. Frank et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Defensins and other antimicrobial peptides in inflammatory bowel disease
Jan Wehkamp et al.
CURRENT OPINION IN GASTROENTEROLOGY (2007)
Induction of human β-defensin 2 by the probiotic Escherichia coli nissle 1917 is mediated throuah flagellin
Miriam Schlee et al.
INFECTION AND IMMUNITY (2007)
Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease
Michael Schmid et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Comparative study of the intestinal mucus barrier in normal and inflamed colon
Alexander Swidsinski et al.
GUT (2007)
Reduced mucosal antimicrobial activity in Crohn's disease of the colon
Sabine Nuding et al.
GUT (2007)
NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease
Laurent Peyrin-Biroulet et al.
JOURNAL OF ENDOTOXIN RESEARCH (2007)
The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients
Rodrigo Bibiloni et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
Juergen Schauber et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
C Prantera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2
E Voss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon
Klaus Fellermann et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Reduced Paneth cell α-defensins in ileal Crohn's disease
J Wehkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease
A Swidsinski et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
W Stremmel et al.
GUT (2005)
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease
J Wehkamp et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Wnt signalling induces maturation of Paneth cells in intestinal crypts
JH van Es et al.
NATURE CELL BIOLOGY (2005)
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract
KS Kobayashi et al.
SCIENCE (2005)
Intestinal stem cells
SJ Leedham et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Trichuris suis therapy in Crohn's disease
RW Summers et al.
GUT (2005)
Defensin-mediated innate immunity in the small intestine
AJ Ouellette
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2004)
Paneth cell granule depletion in the human small intestine under infective and nutritional stress
P Kelly et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression
J Wehkamp et al.
GUT (2004)
β-Defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells
P Vora et al.
JOURNAL OF IMMUNOLOGY (2004)
Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2
SE Girardin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Extensive normal copy number variation of a β-defensin antimicrobial-gene cluster
EJ Hollox et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Inducible and constitutive β-defensins are differentially expressed in Crohn's disease and ulcerative colitis
J Wehkamp et al.
INFLAMMATORY BOWEL DISEASES (2003)
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
NH Salzman et al.
NATURE (2003)
Host recognition of bacterial muramyl dipeptide mediated through NOD2
N Inohara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?
N Papo et al.
PEPTIDES (2003)
Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis
A Fahlgren et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Inflammatory bowel disease
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease
J Wehkamp et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Innate immunity and colonic inflammation -: Enhanced expression of epithelial α-defensins
J Wehkamp et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
AP Cuthbert et al.
GASTROENTEROLOGY (2002)
Antimicrobial peptides of multicellular organisms
M Zasloff
NATURE (2002)
Requirement of Math1 for secretory cell lineage commitment in the mouse intestine
Q Yang et al.
SCIENCE (2001)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
E Cario et al.
INFECTION AND IMMUNITY (2000)
Mucins and inflammatory bowel disease
T Shirazi et al.
POSTGRADUATE MEDICAL JOURNAL (2000)
Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria
T Ayabe et al.
NATURE IMMUNOLOGY (2000)